Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup
Subgroup analysis
Regimen
DOI:
10.3389/fphar.2024.1398879
Publication Date:
2024-05-09T05:06:13Z
AUTHORS (2)
ABSTRACT
Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not high-risk
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (20)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....